ProBiotix Health Plc (AQU:PBX)
8.25
-0.25 (-2.94%)
At close: Jun 5, 2025
ProBiotix Health Balance Sheet
Financials in millions GBP. Fiscal year is January - December.
Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 |
---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 |
Cash & Equivalents | 1.65 | 1.5 | 1.74 | 0.15 | 0.14 | Upgrade
|
Cash & Short-Term Investments | 1.65 | 1.5 | 1.74 | 0.15 | 0.14 | Upgrade
|
Cash Growth | 9.59% | -13.68% | 1091.38% | 5.37% | -22.96% | Upgrade
|
Accounts Receivable | 0.14 | 0.2 | 0.4 | 0.72 | 0.41 | Upgrade
|
Other Receivables | 0.1 | 0.05 | 0.09 | 0.02 | 0.06 | Upgrade
|
Receivables | 0.24 | 0.25 | 0.49 | 0.74 | 0.48 | Upgrade
|
Inventory | 0.03 | 0.1 | 0.05 | 0.01 | - | Upgrade
|
Prepaid Expenses | 0.02 | 0.01 | 0.01 | 0 | 0 | Upgrade
|
Total Current Assets | 1.93 | 1.87 | 2.29 | 0.9 | 0.62 | Upgrade
|
Property, Plant & Equipment | 0.01 | - | - | - | - | Upgrade
|
Other Intangible Assets | 0.24 | 0.3 | 0.36 | 0.35 | 0.36 | Upgrade
|
Total Assets | 2.18 | 2.17 | 2.64 | 1.25 | 0.98 | Upgrade
|
Accounts Payable | 0.03 | 0.47 | 0.18 | 0.2 | 0.15 | Upgrade
|
Accrued Expenses | 0.06 | 0.07 | 0.08 | 0.05 | 0.04 | Upgrade
|
Current Income Taxes Payable | 0.01 | - | - | 0 | - | Upgrade
|
Other Current Liabilities | 0.1 | 0.03 | 0.05 | 0.25 | 0.15 | Upgrade
|
Total Current Liabilities | 0.19 | 0.57 | 0.31 | 0.5 | 0.34 | Upgrade
|
Long-Term Debt | - | - | - | 1.08 | 1.02 | Upgrade
|
Long-Term Deferred Tax Liabilities | 0.06 | 0.08 | 0.09 | 0.08 | 0.07 | Upgrade
|
Total Liabilities | 0.25 | 0.64 | 0.4 | 1.67 | 1.44 | Upgrade
|
Common Stock | 0.08 | 0.06 | 0.06 | 0 | 0 | Upgrade
|
Additional Paid-In Capital | 4.53 | 3.34 | 3.34 | - | - | Upgrade
|
Retained Earnings | -1.79 | -0.98 | -0.23 | -0.54 | -0.58 | Upgrade
|
Comprehensive Income & Other | -0.9 | -0.89 | -0.92 | 0.12 | 0.12 | Upgrade
|
Shareholders' Equity | 1.92 | 1.53 | 2.25 | -0.42 | -0.46 | Upgrade
|
Total Liabilities & Equity | 2.18 | 2.17 | 2.64 | 1.25 | 0.98 | Upgrade
|
Total Debt | - | - | - | 1.08 | 1.02 | Upgrade
|
Net Cash (Debt) | 1.65 | 1.5 | 1.74 | -0.94 | -0.88 | Upgrade
|
Net Cash Growth | 9.59% | -13.68% | - | - | - | Upgrade
|
Net Cash Per Share | 0.01 | 0.01 | 0.02 | -9.38 | -8.82 | Upgrade
|
Filing Date Shares Outstanding | 158.17 | 121.67 | 121.67 | 0.1 | 0.1 | Upgrade
|
Total Common Shares Outstanding | 158.17 | 121.67 | 121.67 | 0.1 | 0.1 | Upgrade
|
Working Capital | 1.74 | 1.31 | 1.98 | 0.4 | 0.27 | Upgrade
|
Book Value Per Share | 0.01 | 0.01 | 0.02 | -4.20 | -4.56 | Upgrade
|
Tangible Book Value | 1.69 | 1.23 | 1.89 | -0.77 | -0.82 | Upgrade
|
Tangible Book Value Per Share | 0.01 | 0.01 | 0.02 | -7.66 | -8.19 | Upgrade
|
Machinery | 0.01 | - | - | - | - | Upgrade
|
Updated Aug 30, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.